Review



efficacy against e coli atcc 25922  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC efficacy against e coli atcc 25922
    In vitro stability analysis of peptides. ( A ) Fold changes in MICs of GSLPs against <t>E.</t> <t>coli</t> 25922 and S. aureus 29213 in the presence of trypsin and pepsin (2–8 mg/mL). ( B ) MICs of IPr against E. coli 25922 and S. aureus 29213 after incubation with proteases for different times (1–4 h). ( C ) Retention of IPr after incubation with proteases for different times as determined by HPLC assay. ( D ) MICs of IPr after incubation with human serum for different times. ( E ) Physiological salt stability of IPr. Data in ( B ), ( D ) and ( E ) are presented as mean ± SEM, n = 3. No error bars indicate undetectable variation among three replicates
    Efficacy Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 52741 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/efficacy+against+e+coli+atcc+25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12853757-247-30-34
    Average 99 stars, based on 52741 article reviews
    efficacy against e coli atcc 25922 - by Bioz Stars, 2026-10
    99/100 stars

    Images

    1) Product Images from "Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential"

    Article Title: Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential

    Journal: Journal of Nanobiotechnology

    doi: 10.1186/s12951-026-04053-6

    In vitro stability analysis of peptides. ( A ) Fold changes in MICs of GSLPs against E. coli 25922 and S. aureus 29213 in the presence of trypsin and pepsin (2–8 mg/mL). ( B ) MICs of IPr against E. coli 25922 and S. aureus 29213 after incubation with proteases for different times (1–4 h). ( C ) Retention of IPr after incubation with proteases for different times as determined by HPLC assay. ( D ) MICs of IPr after incubation with human serum for different times. ( E ) Physiological salt stability of IPr. Data in ( B ), ( D ) and ( E ) are presented as mean ± SEM, n = 3. No error bars indicate undetectable variation among three replicates
    Figure Legend Snippet: In vitro stability analysis of peptides. ( A ) Fold changes in MICs of GSLPs against E. coli 25922 and S. aureus 29213 in the presence of trypsin and pepsin (2–8 mg/mL). ( B ) MICs of IPr against E. coli 25922 and S. aureus 29213 after incubation with proteases for different times (1–4 h). ( C ) Retention of IPr after incubation with proteases for different times as determined by HPLC assay. ( D ) MICs of IPr after incubation with human serum for different times. ( E ) Physiological salt stability of IPr. Data in ( B ), ( D ) and ( E ) are presented as mean ± SEM, n = 3. No error bars indicate undetectable variation among three replicates

    Techniques Used: In Vitro, Incubation

    Overall antimicrobial mechanisms of IPr. ( A ) Time-kill curves against E. coli 25922 and S. aureus 29213. ( B ) Effect of IPr on outer membrane permeability of E. coli 25922. ( C ) Effect of IPr on cytoplasmic membrane permeability of E. coli 25922. ( D ) IPr-induced cytoplasmic membrane depolarization of E. coli 25922 and S. aureus 29213. ( E ) IPr-induced inhibition of respiratory chain dehydrogenases in E. coli 25922 and S. aureus 29213. ( F ) Accumulation of intracellular ROS in E. coli 25922 and S. aureus 29213. ( G ) Extracellular ATP release in E. coli 25922 and S. aureus 29213. ( H ) Microscopic characterization of IPr-induced bacterial damage, including fluorescence microscopy with live/dead viability staining (scale bar: 400 μm and 200 μm), TEM (scale bar: 500 nm), and SEM (scale bar: 1 μm). Red arrows indicate prominent morphological damage. Data in ( A ), ( B ), ( E ), ( F ) and ( G ) are presented as mean ± SEM, n = 3. Groups with significant differences ( P < 0.05) are labeled with distinct superscripted letters (a-f). All differences between groups are analyzed by one-way ANOVA followed by Duncan post-test analysis
    Figure Legend Snippet: Overall antimicrobial mechanisms of IPr. ( A ) Time-kill curves against E. coli 25922 and S. aureus 29213. ( B ) Effect of IPr on outer membrane permeability of E. coli 25922. ( C ) Effect of IPr on cytoplasmic membrane permeability of E. coli 25922. ( D ) IPr-induced cytoplasmic membrane depolarization of E. coli 25922 and S. aureus 29213. ( E ) IPr-induced inhibition of respiratory chain dehydrogenases in E. coli 25922 and S. aureus 29213. ( F ) Accumulation of intracellular ROS in E. coli 25922 and S. aureus 29213. ( G ) Extracellular ATP release in E. coli 25922 and S. aureus 29213. ( H ) Microscopic characterization of IPr-induced bacterial damage, including fluorescence microscopy with live/dead viability staining (scale bar: 400 μm and 200 μm), TEM (scale bar: 500 nm), and SEM (scale bar: 1 μm). Red arrows indicate prominent morphological damage. Data in ( A ), ( B ), ( E ), ( F ) and ( G ) are presented as mean ± SEM, n = 3. Groups with significant differences ( P < 0.05) are labeled with distinct superscripted letters (a-f). All differences between groups are analyzed by one-way ANOVA followed by Duncan post-test analysis

    Techniques Used: Membrane, Permeability, Inhibition, Fluorescence, Microscopy, Staining, Labeling

    Related Articles

    In Vitro:

    Article Title: Repurposing zidovudine and 5-fluoro-2′-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity–reducing agent uridine
    Article Snippet: .. Inspired by the promising in vitro results from combining azidothymidine, trimethoprim and uridine against E. coli , we decided to have this combination tested for efficacy against E. coli ATCC 25922 in a murine peritonitis infection model in two different studies. ..

    Article Title: Repurposing zidovudine and 5-fluoro-2'-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity-reducing agent uridine.
    Article Snippet: .. Effects of azidothymidine, trimethoprim and uridine on peritoneal E. coli infection in mice Inspired by the promising in vitro results from combining azidothymidine, trimethoprim and uridine against E. coli, we decided to have this combination tested for efficacy against E. coli ATCC 25922 in a murine peritonitis infection model in two different studies. ..

    Infection:

    Article Title: Repurposing zidovudine and 5-fluoro-2′-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity–reducing agent uridine
    Article Snippet: .. Inspired by the promising in vitro results from combining azidothymidine, trimethoprim and uridine against E. coli , we decided to have this combination tested for efficacy against E. coli ATCC 25922 in a murine peritonitis infection model in two different studies. ..

    Article Title: Repurposing zidovudine and 5-fluoro-2'-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity-reducing agent uridine.
    Article Snippet: .. Effects of azidothymidine, trimethoprim and uridine on peritoneal E. coli infection in mice Inspired by the promising in vitro results from combining azidothymidine, trimethoprim and uridine against E. coli, we decided to have this combination tested for efficacy against E. coli ATCC 25922 in a murine peritonitis infection model in two different studies. ..

    Activity Assay:

    Article Title: Characterization and genome analyses of the novel phages targeting extraintestinal Escherichia coli clones ST131 and ST410.
    Article Snippet: The rise of multidrug-resistant (MDR) extraintestinal pathogenic Escherichia coli (ExPEC) poses a severe healthcare threat, necessitating alternative treatment strategies such as bacteriophage therapy.. In this study, four lytic phages (EC.W2-9, EC.W5-4, EC.W8-1, and EC.W14-2) were isolated from hospital wastewater and characterized for their efficacy against MDR ExPEC isolates.. A total of 44 ExPEC isolates were analyzed, with 41% belonging to sequence type (ST) 131 and 59% to ST410, all exhibiting MDR phenotypes.

    Article Title: Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential
    Article Snippet: .. Fortunately, IPr maintained strong bactericidal activity against both bacterial strains in the presence of seven physiological ions, with only Ca 2+ and Mg 2+ exerting a modest attenuation of its efficacy against E. coli ATCC 25922. .. Interestingly, NH4 + even enhanced the antibacterial potency of IPr against S. aureus ATCC 29213 (Fig. E).



    Similar Products

    99
    ATCC efficacy against e coli atcc 25922
    In vitro stability analysis of peptides. ( A ) Fold changes in MICs of GSLPs against <t>E.</t> <t>coli</t> 25922 and S. aureus 29213 in the presence of trypsin and pepsin (2–8 mg/mL). ( B ) MICs of IPr against E. coli 25922 and S. aureus 29213 after incubation with proteases for different times (1–4 h). ( C ) Retention of IPr after incubation with proteases for different times as determined by HPLC assay. ( D ) MICs of IPr after incubation with human serum for different times. ( E ) Physiological salt stability of IPr. Data in ( B ), ( D ) and ( E ) are presented as mean ± SEM, n = 3. No error bars indicate undetectable variation among three replicates
    Efficacy Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/efficacy+against+e+coli+atcc+25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12853757-247-30-34
    Average 99 stars, based on 1 article reviews
    efficacy against e coli atcc 25922 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC efficacy against e coli atcc accepted manuscript ar tic le in pr es s article
    In vitro stability analysis of peptides. ( A ) Fold changes in MICs of GSLPs against <t>E.</t> <t>coli</t> 25922 and S. aureus 29213 in the presence of trypsin and pepsin (2–8 mg/mL). ( B ) MICs of IPr against E. coli 25922 and S. aureus 29213 after incubation with proteases for different times (1–4 h). ( C ) Retention of IPr after incubation with proteases for different times as determined by HPLC assay. ( D ) MICs of IPr after incubation with human serum for different times. ( E ) Physiological salt stability of IPr. Data in ( B ), ( D ) and ( E ) are presented as mean ± SEM, n = 3. No error bars indicate undetectable variation among three replicates
    Efficacy Against E Coli Atcc Accepted Manuscript Ar Tic Le In Pr Es S Article, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/efficacy+against+e+coli+atcc+25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pm41547795-259-31-35
    Average 99 stars, based on 1 article reviews
    efficacy against e coli atcc accepted manuscript ar tic le in pr es s article - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC antibacterial efficacy against e coli atcc 25922
    Growth of <t>E.</t> <t>coli</t> ATCC 25922 in the presence of Hst5 and Hst8 and copper complexes at a concentration of 200 µg/mL. C—control (peptide-free microbial culture), Hst5—histatin 5, Hst5 Cu—histatin 5 Cu complex, Hst8—histatin 8, Hst8 Cu—histatin 8 Cu complex.
    Antibacterial Efficacy Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/efficacy+against+e+coli+atcc+25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc12787115-172-4-9
    Average 99 stars, based on 1 article reviews
    antibacterial efficacy against e coli atcc 25922 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC similar efficacy against e coli atcc 25922 infection
    Growth of <t>E.</t> <t>coli</t> ATCC 25922 in the presence of Hst5 and Hst8 and copper complexes at a concentration of 200 µg/mL. C—control (peptide-free microbial culture), Hst5—histatin 5, Hst5 Cu—histatin 5 Cu complex, Hst8—histatin 8, Hst8 Cu—histatin 8 Cu complex.
    Similar Efficacy Against E Coli Atcc 25922 Infection, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/efficacy+against+e+coli+atcc+25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pm39718360-250-16-21
    Average 99 stars, based on 1 article reviews
    similar efficacy against e coli atcc 25922 infection - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC vivo efficacy against e coli atcc 25922
    Growth of <t>E.</t> <t>coli</t> ATCC 25922 in the presence of Hst5 and Hst8 and copper complexes at a concentration of 200 µg/mL. C—control (peptide-free microbial culture), Hst5—histatin 5, Hst5 Cu—histatin 5 Cu complex, Hst8—histatin 8, Hst8 Cu—histatin 8 Cu complex.
    Vivo Efficacy Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/efficacy+against+e+coli+atcc+25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pm39718360-233-24-29
    Average 99 stars, based on 1 article reviews
    vivo efficacy against e coli atcc 25922 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    In vitro stability analysis of peptides. ( A ) Fold changes in MICs of GSLPs against E. coli 25922 and S. aureus 29213 in the presence of trypsin and pepsin (2–8 mg/mL). ( B ) MICs of IPr against E. coli 25922 and S. aureus 29213 after incubation with proteases for different times (1–4 h). ( C ) Retention of IPr after incubation with proteases for different times as determined by HPLC assay. ( D ) MICs of IPr after incubation with human serum for different times. ( E ) Physiological salt stability of IPr. Data in ( B ), ( D ) and ( E ) are presented as mean ± SEM, n = 3. No error bars indicate undetectable variation among three replicates

    Journal: Journal of Nanobiotechnology

    Article Title: Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential

    doi: 10.1186/s12951-026-04053-6

    Figure Lengend Snippet: In vitro stability analysis of peptides. ( A ) Fold changes in MICs of GSLPs against E. coli 25922 and S. aureus 29213 in the presence of trypsin and pepsin (2–8 mg/mL). ( B ) MICs of IPr against E. coli 25922 and S. aureus 29213 after incubation with proteases for different times (1–4 h). ( C ) Retention of IPr after incubation with proteases for different times as determined by HPLC assay. ( D ) MICs of IPr after incubation with human serum for different times. ( E ) Physiological salt stability of IPr. Data in ( B ), ( D ) and ( E ) are presented as mean ± SEM, n = 3. No error bars indicate undetectable variation among three replicates

    Article Snippet: Fortunately, IPr maintained strong bactericidal activity against both bacterial strains in the presence of seven physiological ions, with only Ca 2+ and Mg 2+ exerting a modest attenuation of its efficacy against E. coli ATCC 25922.

    Techniques: In Vitro, Incubation

    Overall antimicrobial mechanisms of IPr. ( A ) Time-kill curves against E. coli 25922 and S. aureus 29213. ( B ) Effect of IPr on outer membrane permeability of E. coli 25922. ( C ) Effect of IPr on cytoplasmic membrane permeability of E. coli 25922. ( D ) IPr-induced cytoplasmic membrane depolarization of E. coli 25922 and S. aureus 29213. ( E ) IPr-induced inhibition of respiratory chain dehydrogenases in E. coli 25922 and S. aureus 29213. ( F ) Accumulation of intracellular ROS in E. coli 25922 and S. aureus 29213. ( G ) Extracellular ATP release in E. coli 25922 and S. aureus 29213. ( H ) Microscopic characterization of IPr-induced bacterial damage, including fluorescence microscopy with live/dead viability staining (scale bar: 400 μm and 200 μm), TEM (scale bar: 500 nm), and SEM (scale bar: 1 μm). Red arrows indicate prominent morphological damage. Data in ( A ), ( B ), ( E ), ( F ) and ( G ) are presented as mean ± SEM, n = 3. Groups with significant differences ( P < 0.05) are labeled with distinct superscripted letters (a-f). All differences between groups are analyzed by one-way ANOVA followed by Duncan post-test analysis

    Journal: Journal of Nanobiotechnology

    Article Title: Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential

    doi: 10.1186/s12951-026-04053-6

    Figure Lengend Snippet: Overall antimicrobial mechanisms of IPr. ( A ) Time-kill curves against E. coli 25922 and S. aureus 29213. ( B ) Effect of IPr on outer membrane permeability of E. coli 25922. ( C ) Effect of IPr on cytoplasmic membrane permeability of E. coli 25922. ( D ) IPr-induced cytoplasmic membrane depolarization of E. coli 25922 and S. aureus 29213. ( E ) IPr-induced inhibition of respiratory chain dehydrogenases in E. coli 25922 and S. aureus 29213. ( F ) Accumulation of intracellular ROS in E. coli 25922 and S. aureus 29213. ( G ) Extracellular ATP release in E. coli 25922 and S. aureus 29213. ( H ) Microscopic characterization of IPr-induced bacterial damage, including fluorescence microscopy with live/dead viability staining (scale bar: 400 μm and 200 μm), TEM (scale bar: 500 nm), and SEM (scale bar: 1 μm). Red arrows indicate prominent morphological damage. Data in ( A ), ( B ), ( E ), ( F ) and ( G ) are presented as mean ± SEM, n = 3. Groups with significant differences ( P < 0.05) are labeled with distinct superscripted letters (a-f). All differences between groups are analyzed by one-way ANOVA followed by Duncan post-test analysis

    Article Snippet: Fortunately, IPr maintained strong bactericidal activity against both bacterial strains in the presence of seven physiological ions, with only Ca 2+ and Mg 2+ exerting a modest attenuation of its efficacy against E. coli ATCC 25922.

    Techniques: Membrane, Permeability, Inhibition, Fluorescence, Microscopy, Staining, Labeling

    Growth of E. coli ATCC 25922 in the presence of Hst5 and Hst8 and copper complexes at a concentration of 200 µg/mL. C—control (peptide-free microbial culture), Hst5—histatin 5, Hst5 Cu—histatin 5 Cu complex, Hst8—histatin 8, Hst8 Cu—histatin 8 Cu complex.

    Journal: Molecules

    Article Title: Histatin 8 Interactions with Copper, Zinc, and Nickel Ions, and Its Antimicrobial Profile in Relation to Histatin 5

    doi: 10.3390/molecules31010110

    Figure Lengend Snippet: Growth of E. coli ATCC 25922 in the presence of Hst5 and Hst8 and copper complexes at a concentration of 200 µg/mL. C—control (peptide-free microbial culture), Hst5—histatin 5, Hst5 Cu—histatin 5 Cu complex, Hst8—histatin 8, Hst8 Cu—histatin 8 Cu complex.

    Article Snippet: Hst8 had the best antibacterial efficacy against E. coli ATCC 25922, but it also inhibited the growth of S. aureus (MICs of 160μM and 320 μM, respectively).

    Techniques: Concentration Assay, Control